✦ LIBER ✦

Impaired liver function in stable renal allograft recipients

✍ Scribed by Felix J. Frey; Heinz J. Schaad; Eberhard L. Renner; Fritz F. Horber; Brigitte M. Frey; Rudolf Preisig

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 990 KB
Volume: 9
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840090416

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of split-liver allografts does not i

Use of split-liver allografts does not impair pediatric recipient growth

✍ Alejandro Mejia; Neil Barshes; Glenn Halff; John Goss; W. Kenneth Washburn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

The use of split-liver (SL) allografts continues to be an excellent option for many pediatric recipients. Patient and graft survival with this graft type are comparable to patient and graft survival with whole organ grafts. Quality-of-life issues, specifically growth, for SL recipients have not been

Conversion from liquid to solid rapamyci

Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipients

✍ Patrick A. Kelly; Kimberly Napoli; Barry D. Kahan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Sirolimus (rapamycin, RAPA, Rapamune™) is a potent immunosuppressive agent currently being investigated for prophylaxis against acute rejection episodes in renal transplant recipients. In the present study, stable renal allograft recipients under maintenance therapy with RAPA and cyclosporine (CsA)

Withdrawal of immunosuppression in liver

Withdrawal of immunosuppression in liver allograft recipients

✍ Padbury, Robert T.A. ;Toogood, Giles J. ;McMaster, Paul 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 85 KB

S trategies to minimize the long-term side effects of immunosuppression in liver transplant recipients have included the uniform reduction of all agents in double-or triple-therapy regimens, selective discontinuation of individual agents of such regimens, and the complete withdrawal of all long-term

Posttransplantation de novo tumors in li

Posttransplantation de novo tumors in liver allograft recipients

✍ Penn, Israel 📂 Article 📅 1996 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 714 KB

De novo cancers occurred after transplantation in 8,008 organ allograft recipients, who developed 8,531 different types of malignancy. Three hundred twenty-four liver recipients developed 329 cancers. There were striking differences in the patterns of neoplasms observed when these were compared with

Effect of cyclosporine A on long-term al

Effect of cyclosporine A on long-term allograft function in pediatric renal transplant recipients

✍ A. W. Williams; B. Z. Morgenstern; Mary Murphy; D. S. Milliner 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 460 KB

Papillomavirus DNA in warts of immunosup

Papillomavirus DNA in warts of immunosuppressed renal allograft recipients

✍ A. Gassenmaier; P. Fuchs; H. Schell; H. Pfister 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 417 KB

Renal allograft recipients were shown to have an increased incidence of warts and skin cancers. We examined 148 patients for evidence of wart virus infections and tested for papillomavirus types, which are known to be associated with human malignancies. Of the 148, 36 (24.3%) patients were afflicted